Galiè N, Humbert M, Vachiery JL, et al; Authors/Task Force Members. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016 Jan;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Accessed 26 Nov 2015. PMID: 26320113
Frost A, Badesch D, Giibs JSR, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019 Jan;53(1). doi: 10.1183/13993003.01904-2018. Accessed 06 Mar 2019. PMID: 30545972
Galiè N, Channick RN, Frantz RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019 Jan;53(1). doi: 10.1183/13993003.01889-2018. Accessed 06 Mar 2019. PMID: 30545971
Galiè N, McLaughlin VV, Rubin LJ, et al. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019 Jan 24;53(1):1802148. doi: 10.1183/13993003.02148-2018. Accessed 06 Mar 2019. PMID: 30552088
Hoeper MM, Benza RL, Corris P, et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019 Jan;53(1). doi: 10.1183/13993003.01906-2018. Accessed 06 Mar 2019. PMID: 30545979
Humbert M, Guignabert C, Bonnet S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019 Jan;53(1). doi: 10.1183/13993003.01887-2018. Accessed 06 Mar 2019. PMID: 30545970
Klinger JR, Elliott CG, Levine DJ, et al. Therapy for pulmonary arterial hypertension in adults: update of the CHEST Guideline and Expert Panel Report. Chest. 2019 Mar;155(3):565-586. doi: 10.1016/j.chest.2018.11.030. Accessed 06 Mar 2019. PMID: 30660783
Rubin LJ, Hopkins W. Classification and prognosis of pulmonary hypertension in adults. UptoDate. https://www.uptodate.com. Feb 2019. Accessed 06 Mar 2019.
Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019 Jan;53(1). doi: 10.1183/13993003.01913-2018. Accessed 06 Mar 2019. PMID: 30545968
Condon DF, Nickel NP, Anderson R, et al. The 6th world symposium on pulmonary hypertension: what’s old is new. F1000Res. 2019 Jun;8:F1000 Faculty Rev-888. doi: 10.12688/f1000research.18811.1. Accessed 19 Oct 2020. PMID: 31249672.
Hirani N, Brunner NW, Kapasi A, et al. Canadian Cardiovascular Society/Canadian Thoracic Society position statement on pulmonary hypertension. Can J Cardiol. 2020 Jul;36(7):977-992. doi: 10.1016/j.cjca.2019.11.041. Accessed 19 Oct 2020. PMID: 32682511
Sitbon O, Cottin V, Canuet M, et al. Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension. Eur Respir J. 2020 Sep;56(3):2000673. doi: 10.1183/13993003.00673-2020. Accessed 22 Oct 2020. PMID: 32350101
Thomas CA, Anderson RJ, Condon DF, et al. Diagnosis and management of pulmonary hypertension in the modern era: insights from the 6th world symposium. Pulm Ther. 2020 Jun;6(1):9-22. doi: 10.1007/s41030-019-00105-5. Accessed 19 Oct 2020. PMID: 32048239
Eichstaedt CA, Belge C, Chung WK, et al. Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH. Eur Respir J. 2023 Feb;61(2):2201471. doi: 10.1183/13993003.01471-2022. PMID: 36302552
Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022 Oct;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237. PMID: 36017548
Maron BA. Revised definition of pulmonary hypertension and approach to management: a clinical primer. J Am Heart Assoc. 2023 Apr;12(8):e029024. doi: 10.1161/JAHA.122.029024. PMID: 37026538
Torbic H, Tonelli AR. Sotatercept for pulmonary arterial hypertension in the inpatient setting. J Cardiovasc Pharmacol Ther. 2024 Jan-Dec;29:10742484231225310. doi: 10.1177/10742484231225310. PMID: 38361351
GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7. Accessed 07 Jun 2025. PMID: 39304265
Huang S, Qiu J, Wang A, et al. Burden of pulmonary arterial hypertension in Asia from 1990 to 2021: findings from Global Burden of Disease Study 2021. Chin Med J (Engl). 2025 Jun;138(11). doi: 10.1097/CM9.0000000000003559. Accessed 07 Jun 2025. PMID: 40375470
Hopkins W, Rubin LJ. Treatment and prognosis of pulmonary arterial hypertension in adults (group 1). UpToDate. https://www.uptodate.com. 18 Dec 2025.
Kovacs G, Bartolome S, Denton CP, et al. Definition, classification and diagnosis of pulmonary hypertension. Eur Respir J. 2024 Oct;64(4):2401324. doi: 10.1183/13993003.01324-2024. Accessed 24 Feb 2026. PMID: 39209475
Rubin LJ, Hopkins W. The epidemiology and pathogenesis of pulmonary arterial hypertension (group 1). UpToDate. https://www.uptodate.com. 03 Feb 2026.
Belkin MN, Fudim M, Baratto C, et al. Standardization of baseline and provocative invasive hemodynamic protocols for the evaluation of heart failure and pulmonary hypertension: a scientific statement from the American Heart Association. Circ Heart Fail. 2026 Feb;19(2):e000088. PMID: 41493051
DuBrock HM, Savale L, Sitbon O, et al. International Liver Transplantation Society practice guideline update on portopulmonary hypertension. Liver Transpl. 2026 Feb;32(2):296-314. doi: 10.1097/LVT.0000000000000600. Accessed 31 Aug 2026. PMID: 40094355
Hopkins W, Rubin LJ, Chin K, et al. Treatment of pulmonary arterial hypertension (group 1) in adults: pulmonary hypertension-specific therapy. UpToDate. https://www.uptodate.com. 03 Aug 2026. Accessed 31 Aug 2026.
Sahay S, Visovatti S, Tonelli AR, et al. International Society for Heart and Lung Transplantation (ISHLT) consensus statement on risk stratification in pulmonary arterial hypertension. J Heart Lung Transplant. 2025 Nov;44(11):e73-e131. doi: 10.1016/j.healun.2025.04.015. PMID: 40910964
